Who to call at Heron Therapeutics, Inc., and when
Fundz watches for the moments Heron Therapeutics, Inc. starts buying, and tells you who to reach.
- An alert the day Heron Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Heron Therapeutics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Heron Therapeutics, Inc.. With Fundz connected, it knows.
Heron Therapeutics, Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
AI Executive Summary
AI-powered analysis of 8-K filing content
Heron Therapeutics appointed Thomas Cusack to its Board of Directors on October 27, 2025, for a term expiring at the 2026 Annual Meeting, and he will join the Nominating and Corporate Governance Committee. The appointment was made under a Cooperation Agreement with Rubric Capital Management LP dated August 8, 2025.
Key Takeaways
Thomas Cusack was added to the Board on October 27, 2025, with a term running to the 2026 Annual Meeting of Stockholders.
Cusack will serve on the Nominating and Corporate Governance Committee, which oversees board composition and governance.
3 more takeaways
Related Filings (5)
5 more filings from Heron Therapeutics, Inc. in the last 90 days
Filing Overview
What This Means
Heron Therapeutics, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.